Hereditary Spastic Paraplegia Clinical Trial
Official title:
Identification of Modifying Factors in Hereditary Spastic Paraplegia
A first questionnaire - MODIFSPA conducted in 2014 - identified several environmental factors influencing spasticity in HSP: cold, fatigue, and especially physical activity. In order to improve the care of patients with HSP, The investigator team are looking to deepen the knowledge on physical exercises relieving spasticity as well as to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders. A new questionnaire was therefore created to collect additional information to optimize the care of patients with HSP.
The only common symptom of hereditary spastic paraplegia (HSP) is the presence of spasticity in the lower limbs, associated with a great clinical and genetic heterogeneity. A first MODIFSPA study carried out by the team identified environmental factors influencing spasticity: stress, fatigue, physical activity. In this first study, only spasticity was studied but several symptoms appeared to require medical management according to the patients: fatigue and vesico-sphincter disorders. Following this first study, MODIFSPA2 aims to deepen our knowledge of HSP, via the expertise of patients, to propose a care in adequacy with their needs/demands. Validated scales are included in the questionnaire to evaluate the frequency and intensity of the symptoms most reported by patients (fatigue, pain and mood disorders). Questions are asked to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06117020 -
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
|
Phase 1 | |
| Recruiting |
NCT03981276 -
Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
|
||
| Terminated |
NCT02859428 -
Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31
|
||
| Completed |
NCT03104088 -
Studying Cognition in SPG4
|
||
| Recruiting |
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
||
| Completed |
NCT02604186 -
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia
|
Phase 2/Phase 3 | |
| Completed |
NCT04912609 -
Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)
|
||
| Recruiting |
NCT03206190 -
The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4
|
N/A | |
| Completed |
NCT03627416 -
Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy
|
N/A | |
| Recruiting |
NCT04875416 -
Phenotype, Genotype and Biomarkers 2
|
||
| Withdrawn |
NCT05411627 -
A Pilot Study of Shockwave Therapy in HSP
|
N/A | |
| Completed |
NCT03961906 -
Physiotherapy in Hereditary Spastic Paraplegia
|
Phase 2 | |
| Completed |
NCT05767268 -
Assessment of the Psychophysical State During Rehabilitation Treatment With Lokomat
|
||
| Completed |
NCT02852278 -
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale
|
||
| Completed |
NCT04180098 -
Improving Gait Adaptability in Hereditary Spastic Paraplegia
|
N/A | |
| Completed |
NCT05613114 -
Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia
|
N/A | |
| Completed |
NCT00023075 -
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
|
N/A | |
| Recruiting |
NCT04712812 -
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
|
||
| Recruiting |
NCT05354622 -
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
|
||
| Enrolling by invitation |
NCT02327845 -
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
|